This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Keio University, Shimadzu Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2013
Title: Nobuyuki Susumu: Innovator in Ovarian Cancer Detection
Introduction
Nobuyuki Susumu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the identification of epithelial ovarian cancer. His innovative approach focuses on molecular typing, which offers a new perspective compared to traditional histopathology methods.
Latest Patents
Nobuyuki Susumu holds a patent for a "Marker for identification of tissue type of epithelial ovarian cancer, and method for determination of the occurrence of epithelial ovarian cancer based on tissue type by using the marker." This patent presents a method for identifying the morbidity of epithelial ovarian cancer based on tissue type. The method involves treating a sample from an individual to detect biological molecules that show specific expression patterns in the tissue type of epithelial ovarian cancer. This innovative approach allows for a more accurate identification of the cancer type.
Career Highlights
Throughout his career, Nobuyuki Susumu has worked with notable organizations such as Shimadzu Corporation and Keio University. His work in these institutions has contributed to advancements in medical technology and cancer research. His dedication to improving diagnostic methods has positioned him as a key figure in the field.
Collaborations
Nobuyuki Susumu has collaborated with esteemed colleagues, including Taka-Aki Sato and Atsuhiko Toyama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in cancer research.
Conclusion
Nobuyuki Susumu's contributions to the field of ovarian cancer detection through his innovative patent highlight his commitment to advancing medical diagnostics. His work continues to inspire future research and development in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile